Eledon Pharmaceuticals, Inc. Operating Lease, Expense
Eledon Pharmaceuticals, Inc. (ELDN) reported Operating Lease, Expense of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2026-06-30 was $100.00K, a 0.00% change year-over-year.
- Eledon Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2026-03-31 was $100.00K, a 0.00% change year-over-year.
- Eledon Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2025-12-31 was $100.00K, a 0.00% change year-over-year.
- Eledon Pharmaceuticals, Inc. operating lease, expense for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- Eledon Pharmaceuticals, Inc. operating lease, expense for fiscal 2025 was $400.00K, a 0.00% change from fiscal 2024.
- Eledon Pharmaceuticals, Inc. operating lease, expense for fiscal 2024 was $400.00K, a 0.00% change from fiscal 2023.
- Eledon Pharmaceuticals, Inc. operating lease, expense for fiscal 2023 was $400.00K, a 0.00% change from fiscal 2022.
- Eledon Pharmaceuticals, Inc. operating lease, expense for fiscal 2022 was $400.00K, a 33.33% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-13 | $200.00K 10-Q · filed 2026-08-13 | $300.00K derived: sum of 3 quarters · filed 2026-08-13 | $400.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-13 | $200.00K derived: sum of 2 quarters · filed 2026-05-13 | $300.00K derived: sum of 3 quarters · filed 2026-05-13 | $400.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $200.00K derived: sum of 2 quarters · filed 2026-03-19 | $300.00K derived: sum of 3 quarters · filed 2026-08-13 | $400.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-14 | $200.00K derived: sum of 2 quarters · filed 2026-08-13 | $300.00K 10-Q · filed 2025-11-14 | $400.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-13 | $200.00K 10-Q · filed 2026-08-13 | $300.00K derived: sum of 3 quarters · filed 2026-08-13 | $400.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-13 | $200.00K derived: sum of 2 quarters · filed 2026-05-13 | $300.00K derived: sum of 3 quarters · filed 2026-05-13 | $400.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $200.00K derived: sum of 2 quarters · filed 2026-03-19 | $300.00K derived: sum of 3 quarters · filed 2026-03-19 | $400.00K 10-K · filed 2026-03-19 | |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-14 | $200.00K derived: sum of 2 quarters · filed 2025-11-14 | $300.00K 10-Q · filed 2025-11-14 | $400.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-14 | $200.00K 10-Q · filed 2025-08-14 | $300.00K derived: sum of 3 quarters · filed 2025-08-14 | $400.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $100.00K 10-Q/A · filed 2025-08-14 | $200.00K derived: sum of 2 quarters · filed 2025-08-14 | $300.00K derived: sum of 3 quarters · filed 2025-08-14 | $400.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2023-12-31 | $100.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-14 | $200.00K derived: sum of 2 quarters · filed 2025-08-14 | $300.00K derived: sum of 3 quarters · filed 2025-08-14 | $400.00K 10-K/A · filed 2025-08-14 | |
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $300.00K 10-Q · filed 2024-11-12 | $400.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-19 | $200.00K 10-Q · filed 2024-08-19 | $300.00K derived: sum of 3 quarters · filed 2024-08-19 | $400.00K derived: sum of 4 quarters · filed 2024-08-19 | |
| 2023-03-31 | $100.00K 10-Q/A · filed 2024-08-19 | $200.00K derived: sum of 2 quarters · filed 2024-08-19 | $300.00K derived: sum of 3 quarters · filed 2024-08-19 | $400.00K derived: sum of 4 quarters · filed 2024-08-19 | |
| 2022-12-31 | $100.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-19 | $200.00K derived: sum of 2 quarters · filed 2024-08-19 | $300.00K derived: sum of 3 quarters · filed 2024-08-19 | $400.00K 10-K/A · filed 2024-08-19 | $300.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $300.00K 10-Q · filed 2023-11-09 | $400.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $200.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2023-08-10 | $400.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-11 | $200.00K derived: sum of 2 quarters · filed 2023-05-11 | $300.00K derived: sum of 3 quarters · filed 2023-05-11 | $400.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $200.00K derived: sum of 2 quarters · filed 2023-03-30 | $300.00K derived: sum of 3 quarters · filed 2023-03-30 | $300.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $200.00K derived: sum of 2 quarters · filed 2022-11-14 | $200.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-11 | $100.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | $200.00K 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |